UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 11.541

Sortiert nach

Global COVID-19 Vaccines Strategic Research Report 2024

M2 Presswire, 2024-04-22

2024

Link zum Volltext

Verfügbarkeit prüfen

Major Depressive Disorder Pipeline and Clinical Trials Assessment, 2024 Updates: FDA Approvals, Therapies and Key Companies involved by DelveInsight | Johnson Johnson, Pfizer, AstraZeneca plc, Merck

M2 Presswire, 2024-04-22

2024

Link zum Volltext

Verfügbarkeit prüfen

Global Clinical Trials Market Analysis, Size, and Forecasts 2023 and 2024-2030 Featuring ICON, Wuxi AppTec, SGS, Syneos Health, PRA Health Sciences, Pfizer, IQVIA, Sanofi, and Medpace

M2 Presswire, 2024-04-19

2024

Link zum Volltext

Verfügbarkeit prüfen

Amyotrophic Lateral Sclerosis Pipeline Assessment | In-depth Insights into the Emerging Drugs, Latest FDA, EMA, and PMDA Approvals, Clinical Trials, and Treatment Outlook | GSK, Helixmith, Sanofi

M2 Presswire, 2024-04-19

2024

Link zum Volltext

Verfügbarkeit prüfen

Fibrodysplasia Ossificans Progressiva Pipeline Report, 2024 Updates : In-depth Analysis into the Clinical Trials, Latest FDA, EMA, and PMDA Approvals, Emerging Drugs, Growth Prospects and Companies

M2 Presswire, 2024-04-19

2024

Link zum Volltext

Verfügbarkeit prüfen

Focal Segmental Glomerulosclerosis Pipeline Drugs Analysis Report, 2024 Updates: FDA Approvals, Clinical Trials, Therapies, MOA, ROA by DelveInsight | B. Braun Melsungen, Beckman Coulter, Bayer

M2 Presswire, 2024-04-19

2024

Link zum Volltext

Verfügbarkeit prüfen

Acute Respiratory Distress Syndrome Market Size is anticipated to increase by 2034, estimates DelveInsight

M2 Presswire, 2024-04-18

2024

Link zum Volltext

Verfügbarkeit prüfen

Hypertrophic Cardiomyopathy Pipeline Review, 2024 Updates | Latest FDA, EMA, and PMDA Approvals, Novel and Emerging Therapies, Clinical Trials, and Treatment Outlook | Tenaya Therapeutics, Shandong

M2 Presswire, 2024-04-18

2024

Link zum Volltext

Verfügbarkeit prüfen

Cancer Vaccines Market Size in the 7MM is anticipate to grow by 2032 | DelveInsight

M2 Presswire, 2024-04-18

2024

Link zum Volltext

Verfügbarkeit prüfen

Gene Therapy In CNS Disorder Market Size in the 7MM is expected to grow by 2032 | DelveInsight

M2 Presswire, 2024-04-17

2024

Link zum Volltext

Verfügbarkeit prüfen

Graft vs Host Disease Pipeline Drugs Analysis Report, 2024 Updates: FDA Approvals, Clinical Trials, Therapies, MOA, ROA by DelveInsight | Cellestia Biotech, Pfizer, Chia Tai Tianqing Pharma, Regimmune

M2 Presswire, 2024-04-17

2024

Link zum Volltext

Verfügbarkeit prüfen

Herpes Zoster Pipeline Drugs Analysis Report, 2024 Updates: FDA Approvals, Clinical Trials, Therapies, MOA, ROA by DelveInsight | CPL Biologics, EuBiologics, Moderna, Gene One Life Science, Dynavax

M2 Presswire, 2024-04-15

2024

Link zum Volltext

Verfügbarkeit prüfen

Interstitial Lung Disease Market is Predicted to Exhibit Remarkable Growth During the Forecast Period (2023-2032), Analyzes DelveInsight | J2H Biotech, Crystec Pharma, Apie Therapeutics, BLR Bio

M2 Presswire, 2024-04-15

2024

Link zum Volltext

Verfügbarkeit prüfen

Frontotemporal Dementia Pipeline Drugs Analysis Report, 2024 Updates: FDA Approvals, Clinical Trials, MOA, ROA by DelveInsight | Alector, Oncolys BioPharma, Denali Therapeutics Inc, Passage Bio

M2 Presswire, 2024-04-15

2024

Link zum Volltext

Verfügbarkeit prüfen

iPSC Characterization Kit Market Reviews Analysis Report 2024

M2 Presswire, 2024-04-12

2024

Link zum Volltext

Verfügbarkeit prüfen

In-vitro Transcription Templates Market: Trends, Analysis, and Growth Prospects

M2 Presswire, 2024-04-12

2024

Link zum Volltext

Verfügbarkeit prüfen

Gout Pipeline Review, 2024 Updates | Latest FDA, EMA, and PMDA Approvals, Novel and Emerging Therapies, Clinical Trials, and Treatment Outlook | AstraZeneca, R-Pharm, Allena Pharma, JW Pharma

M2 Presswire, 2024-04-12

2024

Link zum Volltext

Verfügbarkeit prüfen

Biomica to Present at Digestive Disease Week (DDW) Conference 2024 Annual Meeting - Evogene

M2 Presswire, 2024-04-12

2024

Link zum Volltext

Verfügbarkeit prüfen

Metastatic Breast Cancer Pipeline Assessment: FDA, EMA, and PMDA Approvals, Emerging Drugs, Clinical Trials, Therapeutic Analysis, and Growth Prospects | RemeGen, SynCore Biotech, Allarity Therapeutic

M2 Presswire, 2024-04-10

2024

Link zum Volltext

Verfügbarkeit prüfen

Parents and Caregivers Report a Reduction in Anxiety and Distress in Young Cancer Patients Using the My Special Aflac Duck

M2 Presswire, 2024-04-09

2024

Link zum Volltext

Verfügbarkeit prüfen

The Market and Future Potential for Molecular Point-of-Care (mPOC) Report, 11th Edition, with Profiles of 30+ Key Industry Players

M2 Presswire, 2024-04-09

2024

Link zum Volltext

Verfügbarkeit prüfen

Hemophilia A Pipeline Drugs Analysis Report, 2024 Updates: FDA Approvals, Clinical Trials, Therapies, MOA, ROA by DelveInsight | Genentech, Novo Nordisk, Pfizer, Sanofi, Shire, ApcinteX, CSL Behring

M2 Presswire, 2024-04-08

2024

Link zum Volltext

Verfügbarkeit prüfen

Gastroesophageal Reflux Disease Pipeline Assessment: FDA, EMA, and PMDA Approvals, Emerging Drugs, Clinical Trials, Therapeutic Analysis, and Growth Prospects | HK inno.N, Chong Kun Dang Pharma

M2 Presswire, 2024-04-08

2024

Link zum Volltext

Verfügbarkeit prüfen

Hemorrhoids Pipeline Drugs Analysis Report, 2024 Updates: FDA Approvals, Clinical Trials, Therapies, MOA, ROA by DelveInsight | Edesa Biotech, Citius Pharma, Nivagen Pharma

M2 Presswire, 2024-04-08

2024

Link zum Volltext

Verfügbarkeit prüfen

Choroideremia Pipeline Assessment | In-depth Insights into the Emerging Drugs, Latest FDA, EMA, and PMDA Approvals, Clinical Trials, and Treatment Outlook | Curative Biotech, 4D Molecular Therapeutics

M2 Presswire, 2024-04-08

2024

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 11.541

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieM2 Presswire

Suchergebnisse filtern

Filter anzeigen

Publikationsform

Zeitungsartikel
(11.541)

Sprache

Englisch
(11.541)

Erscheinungsjahr

n.n

Thema

Medical Research
(7.333)
Medicine, Experimental
(3.857)
Forecasts And Trends
(3.636)
Clinical Trials
(1.450)
Pharmaceutical Industry
(1.220)
Medical Equipment
(966)
Business
(806)
Medical Equipment And Supplies Industry
(790)
Medical Test Kit Industry
(790)
Marketing Research
(768)
Product Development
(767)
Medical Equipment Industry
(759)
Statistics
(732)
Growth
(710)
Health Aspects
(698)
Industry Forecasts
(604)
Vaccines
(590)
Care And Treatment
(562)
Medical Imaging Equipment
(535)
Drugs
(512)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

Factiva
(11.541)
Nexis Uni
(11.541)

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Global COVID-19 Vaccines Strategic Research Report 2024

Major Depressive Disorder Pipeline and Clinical Trials Assessment, 2024 Updates: FDA Approvals, Therapies and Key Companies involved by DelveInsight | Johnson Johnson, Pfizer, AstraZeneca plc, Merck

Global Clinical Trials Market Analysis, Size, and Forecasts 2023 and 2024-2030 Featuring ICON, Wuxi AppTec, SGS, Syneos Health, PRA Health Sciences, Pfizer, IQVIA, Sanofi, and Medpace

Amyotrophic Lateral Sclerosis Pipeline Assessment | In-depth Insights into the Emerging Drugs, Latest FDA, EMA, and PMDA Approvals, Clinical Trials, and Treatment Outlook | GSK, Helixmith, Sanofi

Fibrodysplasia Ossificans Progressiva Pipeline Report, 2024 Updates : In-depth Analysis into the Clinical Trials, Latest FDA, EMA, and PMDA Approvals, Emerging Drugs, Growth Prospects and Companies

Focal Segmental Glomerulosclerosis Pipeline Drugs Analysis Report, 2024 Updates: FDA Approvals, Clinical Trials, Therapies, MOA, ROA by DelveInsight | B. Braun Melsungen, Beckman Coulter, Bayer

Acute Respiratory Distress Syndrome Market Size is anticipated to increase by 2034, estimates DelveInsight

Hypertrophic Cardiomyopathy Pipeline Review, 2024 Updates | Latest FDA, EMA, and PMDA Approvals, Novel and Emerging Therapies, Clinical Trials, and Treatment Outlook | Tenaya Therapeutics, Shandong

Cancer Vaccines Market Size in the 7MM is anticipate to grow by 2032 | DelveInsight

Gene Therapy In CNS Disorder Market Size in the 7MM is expected to grow by 2032 | DelveInsight

Graft vs Host Disease Pipeline Drugs Analysis Report, 2024 Updates: FDA Approvals, Clinical Trials, Therapies, MOA, ROA by DelveInsight | Cellestia Biotech, Pfizer, Chia Tai Tianqing Pharma, Regimmune

Herpes Zoster Pipeline Drugs Analysis Report, 2024 Updates: FDA Approvals, Clinical Trials, Therapies, MOA, ROA by DelveInsight | CPL Biologics, EuBiologics, Moderna, Gene One Life Science, Dynavax

Interstitial Lung Disease Market is Predicted to Exhibit Remarkable Growth During the Forecast Period (2023-2032), Analyzes DelveInsight | J2H Biotech, Crystec Pharma, Apie Therapeutics, BLR Bio

Frontotemporal Dementia Pipeline Drugs Analysis Report, 2024 Updates: FDA Approvals, Clinical Trials, MOA, ROA by DelveInsight | Alector, Oncolys BioPharma, Denali Therapeutics Inc, Passage Bio

iPSC Characterization Kit Market Reviews Analysis Report 2024

In-vitro Transcription Templates Market: Trends, Analysis, and Growth Prospects

Gout Pipeline Review, 2024 Updates | Latest FDA, EMA, and PMDA Approvals, Novel and Emerging Therapies, Clinical Trials, and Treatment Outlook | AstraZeneca, R-Pharm, Allena Pharma, JW Pharma

Biomica to Present at Digestive Disease Week (DDW) Conference 2024 Annual Meeting - Evogene

Metastatic Breast Cancer Pipeline Assessment: FDA, EMA, and PMDA Approvals, Emerging Drugs, Clinical Trials, Therapeutic Analysis, and Growth Prospects | RemeGen, SynCore Biotech, Allarity Therapeutic

Parents and Caregivers Report a Reduction in Anxiety and Distress in Young Cancer Patients Using the My Special Aflac Duck

The Market and Future Potential for Molecular Point-of-Care (mPOC) Report, 11th Edition, with Profiles of 30+ Key Industry Players

Hemophilia A Pipeline Drugs Analysis Report, 2024 Updates: FDA Approvals, Clinical Trials, Therapies, MOA, ROA by DelveInsight | Genentech, Novo Nordisk, Pfizer, Sanofi, Shire, ApcinteX, CSL Behring

Gastroesophageal Reflux Disease Pipeline Assessment: FDA, EMA, and PMDA Approvals, Emerging Drugs, Clinical Trials, Therapeutic Analysis, and Growth Prospects | HK inno.N, Chong Kun Dang Pharma

Hemorrhoids Pipeline Drugs Analysis Report, 2024 Updates: FDA Approvals, Clinical Trials, Therapies, MOA, ROA by DelveInsight | Edesa Biotech, Citius Pharma, Nivagen Pharma

Choroideremia Pipeline Assessment | In-depth Insights into the Emerging Drugs, Latest FDA, EMA, and PMDA Approvals, Clinical Trials, and Treatment Outlook | Curative Biotech, 4D Molecular Therapeutics

Aktive Filter

Suchergebnisse filtern